These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
388 related items for PubMed ID: 17196621
1. Genetic polymorphism of the angiotensin converting enzyme and L-dopa-induced adverse effects in Parkinson's disease. Lin JJ, Yueh KC, Lin SZ, Harn HJ, Liu JT. J Neurol Sci; 2007 Jan 31; 252(2):130-4. PubMed ID: 17196621 [Abstract] [Full Text] [Related]
4. Genotype and smoking history affect risk of levodopa-induced dyskinesias in Parkinson's disease. Strong JA, Dalvi A, Revilla FJ, Sahay A, Samaha FJ, Welge JA, Gong J, Gartner M, Yue X, Yu L. Mov Disord; 2006 May 31; 21(5):654-9. PubMed ID: 16435402 [Abstract] [Full Text] [Related]
9. Sex differences in clinical and genetic determinants of levodopa peak-dose dyskinesias in Parkinson disease: an exploratory study. Zappia M, Annesi G, Nicoletti G, Arabia G, Annesi F, Messina D, Pugliese P, Spadafora P, Tarantino P, Carrideo S, Civitelli D, De Marco EV, Cirò-Candiano IC, Gambardella A, Quattrone A. Arch Neurol; 2005 Apr 31; 62(4):601-5. PubMed ID: 15824260 [Abstract] [Full Text] [Related]
10. New ideas on the origin of L-dopa-induced dyskinesias: age, genes and neural plasticity. Linazasoro G. Trends Pharmacol Sci; 2005 Aug 31; 26(8):391-7. PubMed ID: 16009432 [Abstract] [Full Text] [Related]
12. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients. Draman CR, Kong NC, Gafor AH, Rahman AF, Zainuddin S, Mustaffa WM, Radzi AM, Shamsul AS. Singapore Med J; 2008 Nov 31; 49(11):924-9. PubMed ID: 19037561 [Abstract] [Full Text] [Related]
13. A hospital-based study: risk factors in development of motor complications in 555 Parkinson's patients on levodopa therapy. Benbir G, Ozekmekçi S, Apaydin H, Delil S, Erginöz E. Clin Neurol Neurosurg; 2006 Dec 31; 108(8):726-32. PubMed ID: 16564615 [Abstract] [Full Text] [Related]
14. The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications. Bialecka M, Kurzawski M, Klodowska-Duda G, Opala G, Tan EK, Drozdzik M. Pharmacogenet Genomics; 2008 Sep 31; 18(9):815-21. PubMed ID: 18698234 [Abstract] [Full Text] [Related]
15. Disordered respiration as a levodopa-induced dyskinesia in Parkinson's disease. Rice JE, Antic R, Thompson PD. Mov Disord; 2002 May 31; 17(3):524-7. PubMed ID: 12112201 [Abstract] [Full Text] [Related]
16. Motor complications in patients form the German Competence Network on Parkinson's disease and the DRD3 Ser9Gly polymorphism. Paus S, Gadow F, Knapp M, Klein C, Klockgether T, Wüllner U. Mov Disord; 2009 May 15; 24(7):1080-4. PubMed ID: 19353703 [Abstract] [Full Text] [Related]
17. [A clinical analysis of L-dopa induced dyskinesia treated by posteroventral pallidotomy for Parkinson's disease]. Zhao G, Li Y, Shao M, Ding Y. Zhonghua Wai Ke Za Zhi; 1999 Aug 15; 37(8):482-4. PubMed ID: 11829894 [Abstract] [Full Text] [Related]
18. The effect of monoamine oxidase B (MAOB) and catechol-O-methyltransferase (COMT) polymorphisms on levodopa therapy in patients with sporadic Parkinson's disease. Białecka M, Droździk M, Kłodowska-Duda G, Honczarenko K, Gawrońska-Szklarz B, Opala G, Stankiewicz J. Acta Neurol Scand; 2004 Oct 15; 110(4):260-6. PubMed ID: 15355491 [Abstract] [Full Text] [Related]
19. Angiotensin converting enzyme gene polymorphism in Turkish asthmatic patients. Eryüksel E, Ceyhan BB, Bircan R, Avşar M, Cirakoğlu B. J Asthma; 2009 May 15; 46(4):335-8. PubMed ID: 19484664 [Abstract] [Full Text] [Related]
20. A CD14 monocyte receptor polymorphism and genetic susceptibility to Parkinson's disease for females. Lin JJ, Chen CH, Yueh KC, Chang CY, Lin SZ. Parkinsonism Relat Disord; 2006 Jan 15; 12(1):9-13. PubMed ID: 16337421 [Abstract] [Full Text] [Related] Page: [Next] [New Search]